Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia

Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia

Background: HER2-targeting therapies may increase the risk of decreased left ventricular ejection fraction (LVEF), potentially leading to heart failure. The growing number of breast cancer survivors due to HER2-targeted treatments necessitates long-term cardiotoxicity management. Method: This retros...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari, Majed Alshamrani, Abdulhalim Kinsara, Atif AlQubbany, Mahasen Alharbi, Abdelmajid Alnatsheh, Meteb Alfoheidi
Format: Article
Language:English
Published: SAGE Publishing 2024-11-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/11795549241297881
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/11795549241297881

Similar Items